Solv, Q4 EPS
Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs.
--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE ... that the company has entered into a definitive agreement with Solventum (NYSE: SOLV) to acquire Solventum’s Purification & ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results